trial · primary record
gemcitabine hydrochloride
Liver Metastases
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2018-02-07 |
| Primary endpoint | Number of Participants With at Least One Dose Limiting Toxicity |
| Registry ID | NCT00645710 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:43.244Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00645710
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Gemcitabine Hydrochloride · approval
- gemcitabine hydrochloride · compound